Trademark Search in Canada

IRFILBRAY

View On IC.GC.CA

REGISTERED

on 8 Nov 2024

Last Applicant/ Owned by

GENZYME CORPORATION

450 Water StreetCambridge, MA 02141

Serial Number

2253761 filed on 24^th Apr 2023

Registration Number

TMA1269012 registered on 8^th Nov 2024

Registration expiry Date

8^th Nov 2034

Correspondent Address

SMART & BIGGAR LP

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

M5H3Y2

IRFILBRAY

Trademark usage description

pharmaceutical preparations for the treatment of autosomal dominant polycystic kidney disease; pharmaceutical preparations for the treatment of lysoso Read More

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of autosomal dominant polycystic kidney disease; pharmaceutical preparations for the treatment of lysosomal storage diseases

Classification kind code

Mark Details

Serial Number

2253761

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 190 on 8^th Nov 2024	Registration Pending
Submitted for opposition 55 on 8^th Nov 2024	Registered
Submitted for opposition 67 on 27^th Sept 2024	Agent Name Changed
Submitted for opposition 42 on 21^st Aug 2024	Advertised
Submitted for opposition 26 on 26^th Jul 2024	Approved
Submitted for opposition 27 on 26^th Jul 2024	Approval Notice Sent
Submitted for opposition 22 on 18^th Jul 2024	Search Recorded
Submitted for opposition 30 on 24^th Apr 2023	Filed
Submitted for opposition 1 on 24^th Apr 2023	Created
Submitted for opposition 31 on 24^th Apr 2023	Formalized

IRFILBRAY

Classification Information

Class [005]Pharmaceutical preparations for the treatment of autosomal dominant polycystic kidney disease; pharmaceutical preparations for the treatment of lysosomal storage diseases

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [005]
Pharmaceutical preparations for the treatment of autosomal dominant polycystic kidney disease; pharmaceutical preparations for the treatment of lysosomal storage diseases